Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING
Journal for ImmunoTherapy of Cancer · 2023-08 · 11 (8) · e006235
DOI: 10.1136/jitc-2022-006235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 28.08.2023. Verfasst von Liqun Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Freiburg Faculty of Medicine, Freiburg, Germany. Hauptthemen laut MEDLINE: DNA, Mitochondrial, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Localized radiotherapy (RT) can cause a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade. However, this effect is still clinically rare and improvements are highly desirable. We investigated whether triple combination with a low dose of clinically approved liposomal doxorubicin (Doxil) could augment abscopal responses compared with RT/αPD-1 and Doxil/αPD-1. We also investigated whether the enhanced abscopal responses depended on the mitochondrial DNA (mtDNA)/cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING)/IFN-I pathway. Materials/methods We used Doxil in combination with RT and αPD-1 in two tumor models (B16-CD133 melanoma and MC38 colon carcinoma) with mice bearing two tumors, only one of which was irradiated. Mechanistic studies on the role of the mtDNA/cGAS/STING/IFN-I axis were performed using inhibitors and knockout cells in vitro as well as in mice.
Results
Addition of a single low dose of Doxil to RT and αPD-1 strongly enhanced the RT/αPD-1-induced abscopal effect in both models. Complete cures of non-irradiated tumors were mainly observed in triple-treated mice. Triple therapy induced more cross-presenting dendritic cells (DCs) and more tumor-specific CD8 + T cells than RT/αPD-1 and Doxil/αPD-1, particularly in non-irradiated tumors. Coincubation of Doxil-treated and/or RT-treated tumor cells with DCs enhanced DC antigen cross-presentation which is crucial for inducing CD8 + T cells. CD8 + T cell depletion or implantation of cGAS-deficient or STING-deficient tumor cells abolished the abscopal effect. Doxorubicin-induced/Doxil-induced IFNβ1 markedly depended on the cGAS/STING pathway. Doxorubicin-treated/Doxil-treated tumor cells depleted of mtDNA secreted less IFNβ1, of the related T cell-recruiting chemokine CXCL10, and ATP; coincubation with mtDNA-depleted tumor cells strongly reduced IFNβ1 secretion by DCs. Implantation of mtDNA-depleted tumor cells, particularly at the non-irradiated/abscopal site, substantially diminished the Doxil-enhanced abscopal effect and tumor infiltration by tumor-specific CD8 + T cells.
Conclusions
These data show that single low-dose Doxil can substantially enhance the RT/αPD-1-induced abscopal effect, with a strong increase in cross-presenting DCs and CD8 + tumor-specific T cells particularly in abscopal tumors compared with RT/αPD-1 and Doxil/αPD-1. Moreover, they indicate that the mtDNA/cGAS/STING/IFN-I axis is important for the immunogenic/immunomodulatory doxorubicin effects. Our findings may be helpful for the planning of clinical radiochemoimmunotherapy trials in (oligo)metastatic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Freiburg Faculty of Medicine, Freiburg, Germany.
- Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
- Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China luorenbu@gmail.com gabriele.niedermann@uniklinik-freiburg.de.
- Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
- Faculty of Biology, University of Freiburg, Freiburg, Germany.
- German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
ORCID-Profile: Gabriele Niedermann
Zitieren
APA
Wang, L., Luo, R., Onyshchenko, K., Rao, X., Wang, M., Menz, B., Gaedicke, S., Grosu, A. L., Firat, E., & Niedermann, G. (2023). Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING. Journal for ImmunoTherapy of Cancer, 11(8), e006235. https://doi.org/10.1136/jitc-2022-006235
Vancouver
Wang L, Luo R, Onyshchenko K, Rao X, Wang M, Menz B, et al. Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING. Journal for ImmunoTherapy of Cancer. 2023;11(8):e006235. doi:10.1136/jitc-2022-006235
BibTeX
@article{Wang2023,
author = {Wang, Liqun and Luo, Ren and Onyshchenko, Kateryna and Rao, Xi and Wang, Meidan and Menz, Beatrice and Gaedicke, Simone and Grosu, Anca-Ligia and Firat, Elke and Niedermann, Gabriele},
title = {Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2023},
volume = {11},
number = {8},
pages = {e006235},
doi = {10.1136/jitc-2022-006235}
}
EUVIMED